Lv71
3870 积分 2022-05-23 加入
Multi-objective antibody design and optimization using machine learning
7小时前
已完结
Rethinking the role of synergy calculations in the next century of drug combination discovery
7小时前
已完结
FDA/CDER/OND Experience With New Approach Methodologies (NAMs)
7小时前
已完结
Evolution of the psoriasis therapy landscape
7小时前
求助中
GLP-1-based therapies for diabetes, obesity and beyond
1天前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
21天前
已完结
FDA/CDER/OND Experience With New Approach Methodologies (NAMs)
25天前
已完结
Rethinking the role of synergy calculations in the next century of drug combination discovery
25天前
已完结
A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs
25天前
已完结
Rethinking the role of synergy calculations in the next century of drug combination discovery
1个月前
已完结
皖公网安备34019202002308
